Retracted:Systematic Review: Benefits and Harms of Transarterial Embolisation for Treating Hepatocellular Adenoma

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14044
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Retraction: Systematic Review: Benefits and Harms of Transarterial Embolisation for Treating Hepatocellular Adenoma’ by C. Zhao, S.-L. Pei, A. Cucchetti, T.-J. Tong, Y.-L. Ma, J.-H. Zhong & L.-Q. Li

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Modelling the Benefits and Harms of Surveillance for Hepatocellular Carcinoma: Information to Support Informed Choices

Hepatology
MedicineHepatology
2017English

A Randomised Phase II/III Trial of 3-Weekly Cisplatin-Based Sequential Transarterial Chemoembolisation vs Embolisation Alone for Hepatocellular Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2013English

Lipiodol Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review of Efficacy and Safety Data

Hepatology
MedicineHepatology
2016English

Benefits and Harms of Mobile Devices for High School Students

Archiv Euromedica
2020English

Transarterial Chemoembolization for Hepatocellular Carcinoma: An Evidence-Based Review of Its Place in Therapy

Journal of Hepatocellular Carcinoma
2015English

Balancing Benefits and Harms in Health Care: Information About Benefits and Harms Should Be Accessible to Patients

BMJ
2004English

Caring for Esteem and Intellectual Reputation: Some Epistemic Benefits and Harms

Royal Institute of Philosophy Supplement
2018English

Locoregenional Therapy for Hepatocellular Carcinoma: Transarterial Chemoembolization Versus Transarterial Radioembolization Versus Stereotactic Body Radiotherapy

Clinical Liver Disease
Hepatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy